{
    "clinical_study": {
        "@rank": "8051", 
        "arm_group": [
            {
                "arm_group_label": "Computerized cognitive rehabilitation", 
                "arm_group_type": "Experimental", 
                "description": "-Computerized cognitive rehabilitation: 20 one-hour-sessions of computerized cognitive rehabilitation."
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "-placebo group simultaneously received 20 one-hour-sessions of placebo of computerized training."
            }, 
            {
                "arm_group_label": "Ritalin", 
                "arm_group_type": "Experimental", 
                "description": "-10mg Ritalin tablets per day during tow months."
            }
        ], 
        "brief_summary": {
            "textblock": "Current research aimed to compare the efficacy of computer-assisted cognitive rehabilitation\n      (CACR), stimulant drugs and placebo on executive functions and clinical symptoms of children\n      with attention deficit/hyperactivity disorder (ADHD)."
        }, 
        "brief_title": "Comparison of the Computer-assisted Cognitive Rehabilitation, Placebo and Drug Therapy in the Treatment of ADHD", 
        "completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "condition": "Attention Deficit Disorder With Hyperactivity", 
        "condition_browse": {
            "mesh_term": [
                "Attention Deficit Disorder with Hyperactivity", 
                "Hyperkinesis"
            ]
        }, 
        "detailed_description": {
            "textblock": "the investigators administered a randomized controlled trial (RCT) through random assignment\n      of ADHD subjects in to three different groups to compare the effects of CACR,\n      immediate-release methylphenidate, and a Placebo treatment (i.e. some computerized tasks\n      assumed not have any therapeutic effects)on ADHD children's performance."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ADHD diagnosis\n\n          -  age between 7 and 12\n\n          -  IQ > 85\n\n        Exclusion Criteria:\n\n          -  sever co-morbid disorder\n\n          -  seizure\n\n          -  IQ < 85\n\n          -  disability\n\n          -  sever medical condition"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "12 Years", 
            "minimum_age": "7 Years"
        }, 
        "enrollment": {
            "#text": "33", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 29, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01675804", 
            "org_study_id": "83-6516"
        }, 
        "intervention": [
            {
                "arm_group_label": "Computerized cognitive rehabilitation", 
                "description": "- Computerized cognitive rehabilitation: 20 one-hour-sessions of computerized cognitive rehabilitation.", 
                "intervention_name": "Computerized cognitive rehabilitation", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Ritalin", 
                "description": "-drug therapy: 2 or 3 doses of 10mg tablets of Immediate-release Methylphenidate (Ritalin)per day.", 
                "intervention_name": "Ritalin", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Methylphenidate"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "ADHD", 
        "lastchanged_date": "August 29, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tehran", 
                    "country": "Iran, Islamic Republic of"
                }, 
                "name": "Counseling and Psychological Services Center of Department of education and training of region 9 of Tehran"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "3", 
        "official_title": "Comparison of the Efficacy of Computer-assisted Cognitive Rehabilitation (CACR), Stimulants Drug, and Placebo on Executive Functions and the Clinical Symptoms of Children With Attention Deficit/ Hyperactivity Disorder", 
        "overall_official": [
            {
                "last_name": "Saeed Azami, MSc", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Department of Clinical Psychology of Allameh Tabataba'i University, Tehran, Iran.", 
                "last_name": "Alireza Moghadas, PHD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Department of Clinical Psychology of Allameh Tabataba'i University, Tehran, Iran.", 
                "last_name": "Faramarz Sohrabi, PHD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Department of psychology of exceptional children of University of Semnan, Semnan, Iran.", 
                "last_name": "Morteza Nazifi, PHD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The research design was experimental type and pretest, post-test, and follow-up with two experimental groups. All of participants were assessed about executive functions(working memory, inhibition response,planning,sustain attention)and clinical symptoms of attention deficit hyperactive disorder in duration of before, after interventions (i.e. after 8 weeks), and 3 month after the interventions were stop.", 
            "measure": "changes from baseline in Executive Functions(working memory, inhibition response,planning,sustain attention)and clinical symptoms of attention deficit hyperactive disorder at 5 months", 
            "safety_issue": "Yes", 
            "time_frame": "5 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01675804"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Allameh Tabatabai University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Allameh Tabatabai University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}